Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04157751
Recruitment Status : Recruiting
First Posted : November 8, 2019
Last Update Posted : May 6, 2021
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Boehringer Ingelheim

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : May 25, 2021
Estimated Study Completion Date : June 8, 2021